eggXYt
Pre-incubation Sex Identification of Embryonic Chickens
Company Overview
Snapshot
Founded in October 2016 by Yehuda Elram and Daniel Offen, eggXYt operates with 1–10 employees. The company has raised $604K across four funding rounds from two investors. In April 2021, eggXYt secured funding from FoodLab Capital, highlighting continued investor interest in its innovative agricultural technology.
Business overview
eggXYt is an AgriFood-tech company developing a proprietary CRISPR-based technology for the pre-incubation sex identification of chick embryos. This technology allows for the detection of a chick's sex immediately after eggs are laid, before the 21-day incubation period. By preventing the unnecessary hatching of male chicks, eggXYt addresses ethical, environmental, and economic challenges in egg and poultry production, aiming to integrate these eggs into the food industry rather than culling male chicks. The company operates within the Agriculture & Food Technologies sector, focusing on sustainable farming, genetics, and smart farming solutions for the poultry livestock market.
Strategic signal
In December 2020, eggXYt licensed the GEiGS™ Technology Platform from Tropic Biosciences to develop resistance against the Avian Influenza Virus in chickens. This strategic collaboration signals eggXYt's expansion beyond sex identification into broader poultry health and disease prevention, demonstrating a commitment to leveraging genetic technology for significant industry challenges and potentially opening new market opportunities for the company.
Log in to access full profile ›Company Intelligence Q&A
- What is eggXYt's core technology?
- eggXYt develops a CRISPR-based proprietary technology that identifies the sex of chick embryos immediately after eggs are laid, prior to incubation. This method aims to prevent the culling of male chicks in the poultry industry.
- When was eggXYt founded and by whom?
- eggXYt was founded in October 2016 by Yehuda Elram and Daniel Offen.
- What significant partnership did eggXYt announce in December 2020?
- In December 2020, eggXYt licensed the GEiGS™ Technology Platform from Tropic Biosciences for a project focused on developing resistance against the Avian Influenza Virus in chickens.
- What award did eggXYt win in March 2019?
- In March 2019, eggXYt won the Technology Research Award at CleanEquity® Monaco 2019, hosted by Innovator Capital.